SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of the Report: January 12, 1996 Commission file
number 1-5805
CHEMICAL BANKING CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 13-2624428
(State or other jurisdiction (I.R.S. Employer
of incorporation) Identification No.)
270 Park Avenue, New York, New York 10017-2070
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (212) 270-6000
<PAGE>
Items 5. Other Events
On January 5, 1996, the Board of Governors of the Federal Reserve System and
the Office of the State Bank Commissioner of Delaware approved the applications
for the merger of Chemical Banking Corporation, a Delaware corporation
("Chemical"), and The Chase Manhattan Corporation, a Delaware corporation
("Chase"). On January 11, 1996, Chemical received approval from the New York
State Banking Department to merge with Chase. As a result, Chemical and Chase
have received all regulatory approvals necessary to consummate their merger.
The merger is scheduled to close no later than the end of the first quarter
of1996.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
CHEMICAL BANKING CORPORATION
(Registrant)
Dated: January 12, 1996 By /s/John B. Wynne
John B. Wynne
Secretary
